Trial
NCT01538966
Acromegaly Combination Treatment Study
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Cedars-Sinai Medical Center
Collaborators
—
Condition
Acromegaly
Intervention
Pegvisomant
Why stopped
Review of the 12-month data showed patients who deviated from protocol with full IRB monitoring and reporting could not be optimally analyzed. Reopening the study for new enrollment is not feasible and the study was terminated with IRB approval.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-04